The Current Ratio as of November 2024 (TTM) for Equillium, Inc. (EQ) is 3.04

According to Equillium, Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 3.04. This represents a change of 37.97% compared to the average of 2.21 of the last 4 quarters.

Equillium, Inc. (EQ) Historical Current Ratio (quarterly & annually)

How has EQ Current Ratio performed in the past?

The mean historical Current Ratio of Equillium, Inc. over the last ten years is 12.20. The current 3.04 Current Ratio has changed 2.39% with respect to the historical average. Over the past ten years (40 quarters), EQ's Current Ratio was at its highest in in the December 2018 quarter at 33.12. The Current Ratio was at its lowest in in the June 2017 quarter at 0.

Equillium, Inc. (EQ) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Equillium, Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Equillium, Inc. (EQ) Average Current Ratio

How has EQ Current Ratio performed in the past?

The current Current Ratio of Equillium, Inc. (EQ) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Equillium, Inc. (EQ) Current Ratio vs. Peers

How is EQ’s Current Ratio compared to its peers?

Equillium, Inc.’s Current Ratio is less than Lyra Therapeutics, Inc. (3.64), less than HOOKIPA Pharma Inc. (3.26), less than LianBio (10.06), less than Jasper Therapeutics, Inc. (7.61), less than Cingulate Inc. (7.35K), less than SAB Biotherapeutics, Inc. (3.69), less than Anebulo Pharmaceuticals, Inc. (3.45), less than Cadrenal Therapeutics, Inc. Common Stock (3.69), less than Monopar Therapeutics Inc. (5.41K), greater than Spero Therapeutics, Inc. (2.68), less than Bolt Biotherapeutics, Inc. (3.16), greater than Coherus BioSciences, Inc. (1.25), less than Gracell Biotechnologies Inc. (7.73), less than Neoleukin Therapeutics, Inc. (15.33), less than Ikena Oncology, Inc. (15.32), less than Werewolf Therapeutics, Inc. (10.10), less than Edgewise Therapeutics, Inc. (26.35), greater than Quoin Pharmaceuticals, Ltd. (3.02), less than Pasithea Therapeutics Corp. (14.81), less than aTyr Pharma, Inc. (6.07), less than Trevi Therapeutics, Inc. (7.38), greater than Cue Biopharma, Inc. (2.22), less than AN2 Therapeutics, Inc. (9.75), less than BioAtla, Inc. (3.11),

Build a custom stock screener for Equillium, Inc. (EQ) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Equillium, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Equillium, Inc. (EQ) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Equillium, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.